To provide income, with prospects of capital and income growth through investment in stocks and shares.
Name | % Net Assets |
---|---|
BP | 8.4% |
Royal Dutch Shell | 8.3% |
HSBC | 5.8% |
GlaxoSmithKline | 5.3% |
Vodafone | 4.9% |
AstraZeneca | 4.5% |
Barclays | 3.0% |
BHP Billiton | 2.9% |
British American Tobacco | 2.6% |
Reckitt Benckiser | 2.4% |
Key | % Net Assets |
---|---|
BP | 8.4% |
Royal Dutch Shell | 8.3% |
HSBC | 5.8% |
GlaxoSmithKline | 5.3% |
Other | 72.2% |
Date | 14-Feb-2020 |
---|---|
NAV | 531.30p |
Currency | GBP |
Change | 2.00p |
% | 0.38% |
YTD change | 531.30p |
YTD % | n/a |
Fund Inception | 01/11/1959 |
---|---|
Fund Manager | J. Illsley / J.Streeter |
TER | 1.68 (31-Jan-2013) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £100 |
Savings | £100 |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.06 |
You are here: research